A carregar...
Oncological outcomes classified according to metastatic lesions in the era of molecular targeted drugs for metastatic renal cancer
Since the introduction of molecular targeted agents for the treatment of metastatic renal cell cancer (mRCC), several treatment outcomes, including those from our facilities, have been reported. However, the outcome of these drugs, classified by the metastatic organs, is not well known. The present...
Na minha lista:
| Publicado no: | Mol Clin Oncol |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
D.A. Spandidos
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5958790/ https://ncbi.nlm.nih.gov/pubmed/29844909 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1614 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|